Sysmex : OncoGuide™ NCC Oncopanel System Receives Ins

Sysmex : OncoGuide™ NCC Oncopanel System Receives Insurance Coverage as a Companion Diagnostic for Futibatinib, a Treatment for Advanced Biliary Tract Cancer -Today at 02:04 am

Aug. 30, 2023

Sysmex Corporation announces that the OncoGuide™ NCC Oncopanel System is now covered by health insurance in Japan as a companion diagnostic for...

Related Keywords

Japan , , National Cancer Center , Sysmex Group , Cancer Statistics National Registry , Cancer Information Service , National Cancer Incidence Data , Sysmex Corporation , Taiho Pharmaceutical , Cancer Statistics , National Cancer Registry , Annual Report , Hospital Based Cancer Registries , Aggregate Results , Survival Report , Hospital Based Cancer , Markets ,